University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.
Five COVID-19 Projects at UCSD Receive $33 million from NIH genengnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from genengnews.com Daily Mail and Mail on Sunday newspapers.
E-Mail
IMAGE: A nurse tests students for COVID-19 as they arrive on the UC San Diego campus. view more
Credit: Erik Jepsen/UC San Diego
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.
UC San Diego receives $33 million from NIH for five COVID-19 diagnostic projects
University of California San Diego was awarded five Rapid Acceleration of Diagnostics (RADx) projects by the National Institutes of Health (NIH), totaling nearly $33 million over four years. The purpose of the RADx initiative is to speed innovation in the development, commercialization and implementation of technologies for COVID-19 testing.
There are several programs within the RADx initiative, including the RADx Underserved Populations (RADx-UP) program, which funds projects aimed at understanding why some communities are disproportionately affected by COVID-19 and reducing the factors associated with these disparities, and the RADx Radical (RADx-rad) program, which supports innovative approaches to addressing gaps in COVID-19 testing.